For example, blocking CCR2 or CCL2 (CCR2 ligand) expression in tumor cells is particularly effective in alleviating the tumor progression and overcoming the resistance to anti-PD-1 therapy after incomplete radiofrequency ablation (138). The gene discussed is CCL2; the disease is neoplasm.